Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - zoledronic acid monohydrate, quantity: 4.264 mg (equivalent: zoledronic acid, qty 4 mg) - injection, concentrated - excipient ingredients: sodium citrate dihydrate; mannitol; water for injections - zoledronic acid accord is indicated:,for the prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone.,for treatment of tumour-induced hypercalcaemia.,as an adjunct to adjuvant treatment for women with early breast cancer who are in established menopause.

Australia - English - Department of Health (Therapeutic Goods Administration)

scigen australia pty ltd - zoledronic acid, quantity: 4 mg (equivalent: zoledronic acid monohydrate, qty 4.264 mg) - injection, solution - excipient ingredients: water for injections; mannitol; nitrogen; sodium citrate dihydrate - prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone. treatment of tumour-induced hypercalcaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

scigen australia pty ltd - zoledronic acid, quantity: 4 mg (equivalent: zoledronic acid monohydrate, qty 4.264 mg) - injection, concentrated - excipient ingredients: mannitol; sodium citrate dihydrate; water for injections; nitrogen - prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in patients with advanced malignancies involving bone. treatment of tumor-induced hypercalcaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - disodium pamidronate -

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - pamidronate disodium pentahydrat - pdr/conc/soln for infus - 30 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - pamidronate disodium pentahydrat - pdr/conc/soln for infus - 90 anhyd milligrams

Egypt - English - EDA (Egyptian Drug Authority)

novartis pharma egypt - injection - 15 mg

Egypt - English - EDA (Egyptian Drug Authority)

novartis pharma egypt - injection - 15 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis - pamidronate disodium - injection - 15 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis - pamidronate disodium - injection - 30 mg